SCHEMBL4401889

SCHEMBL4401889

CCCOc1ccc(/C=C2\CC(=O)OC2=O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.53
KDM4E B2RXH2 2/20 0.53
POLB P06746 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
PIM1 P11309 1/20 0.52
PIM2 Q9P1W9 1/20 0.52
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAOB P27338 6/20 0.43
MAOA P21397 5/20 0.43
BCHE P06276 4/20 0.43
ACHE P22303 4/20 0.43
NPC1 O15118 1/20 0.42
CASP3 P42574 1/20 0.42
RAB9A P51151 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
ALOX5 P09917 3/20 0.42
ALDH1A1 P00352 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4427728 0.89 MAPT (0.43) MAPTKDM4EPOLBL3MBTL1PIM1
SCHEMBL4400352 0.87 MAOB (0.41) MAPTKDM4EPOLBL3MBTL1PIM1
SCHEMBL9049784 0.81 DYRK1A (0.59) MAPTKDM4EPOLBPIM1PIM2
SCHEMBL9049778 0.81 DYRK1A (0.59) MAPTKDM4EPOLBPIM1PIM2
SCHEMBL9046652 0.78 KMT2A (0.47) MAPTKDM4EL3MBTL1MEN1KMT2A
SCHEMBL9046644 0.78 KMT2A (0.47) MAPTKDM4EL3MBTL1MEN1KMT2A
SCHEMBL9049098 0.76 KMT2A (0.51) MAPTKDM4EPOLBPIM1PIM2
SCHEMBL9049105 0.76 KMT2A (0.51) MAPTKDM4EPOLBPIM1PIM2
SCHEMBL11847128 0.75 CYP1A2 (0.60) MAPTKDM4EPOLBL3MBTL1PIM1
SCHEMBL9619525 0.75 CYP1A2 (0.65) MAPTKDM4EPOLBL3MBTL1PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120107239-A1 Precursor of Molecular Probe for Pancreatic Islet Imaging and Use of the Same ARKRAY, INC. (JP) 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120107239-A1 Precursor of Molecular Probe for Pancreatic Islet Imaging and Use of the Same OGFRL1, OXSR1, IAPP MAPT 4813/4885KDM4E 4799/4885POLB 2873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.